Helicobacter pylori eradication increases nocturnal acid breakthrough

Aliment Pharmacol Ther. 2000 Jul;14(7):961-2. doi: 10.1046/j.1365-2036.2000.00769.x.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents / therapeutic use*
  • Double-Blind Method
  • Gastric Acid / metabolism*
  • Helicobacter Infections / drug therapy*
  • Helicobacter Infections / metabolism
  • Helicobacter pylori* / drug effects
  • Humans
  • Hydrogen-Ion Concentration
  • Lansoprazole
  • Omeprazole / analogs & derivatives*
  • Omeprazole / therapeutic use*
  • Proton Pump Inhibitors

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Ulcer Agents
  • Proton Pump Inhibitors
  • Lansoprazole
  • Omeprazole